Principal Financial Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,051
| Closed | -$719K | – | 2484 |
|
|
2023
Q2 | $719K | Sell |
7,051
-941
| -12% | -$95.9K | ﹤0.01% | 1887 |
|
|
2023
Q1 | $727K | Sell |
7,992
-207
| -3% | -$18.8K | ﹤0.01% | 1904 |
|
|
2022
Q4 | $311K | Buy |
+8,199
| New | +$311K | ﹤0.01% | 2091 |
|
|
2022
Q3 | – | Sell |
-7,371
| Closed | -$224K | – | 2594 |
|
|
2022
Q2 | $224K | Buy |
+7,371
| New | +$224K | ﹤0.01% | 2266 |
|
|
2021
Q4 | – | Sell |
-11,622
| Closed | -$1.17M | – | 2671 |
|
|
2021
Q3 | $1.17M | Buy |
11,622
+221
| +2% | +$22.2K | ﹤0.01% | 1974 |
|
|
2021
Q2 | $1.61M | Buy |
11,401
+2,386
| +26% | +$338K | ﹤0.01% | 1955 |
|
|
2021
Q1 | $899K | Buy |
9,015
+306
| +4% | +$30.5K | ﹤0.01% | 2018 |
|
|
2020
Q4 | $1.08M | Sell |
8,709
-5
| -0.1% | -$618 | ﹤0.01% | 1930 |
|
|
2020
Q3 | $849K | Sell |
8,714
-5,221
| -37% | -$509K | ﹤0.01% | 1904 |
|
|
2020
Q2 | $2.17M | Buy |
13,935
+3,360
| +32% | +$524K | ﹤0.01% | 1678 |
|
|
2020
Q1 | $1.53M | Buy |
10,575
+1,675
| +19% | +$242K | ﹤0.01% | 1661 |
|
|
2019
Q4 | $1.82M | Buy |
8,900
+476
| +6% | +$97.3K | ﹤0.01% | 1742 |
|
|
2019
Q3 | $676K | Buy |
8,424
+168
| +2% | +$13.5K | ﹤0.01% | 1890 |
|
|
2019
Q2 | $779K | Buy |
8,256
+937
| +13% | +$88.4K | ﹤0.01% | 1880 |
|
|
2019
Q1 | $626K | Buy |
+7,319
| New | +$626K | ﹤0.01% | 1892 |
|
|
2018
Q4 | – | Sell |
-3,069
| Closed | -$251K | – | 2329 |
|
|
2018
Q3 | $251K | Buy |
+3,069
| New | +$251K | ﹤0.01% | 2118 |
|